SEARCH

SEARCH BY CITATION

References

  • 1
    Kang V. The influence of geography and ethnicity in irritable bowel syndrome. Aliment Pharmacol Ther 2005; 21: 66376.
  • 2
    Manning AP, Thompson WG, Heaton KW, et al. Towards a positive diagnosis of the irritable bowel syndrome. Br Med J 1978; 2: 6534.
  • 3
    Thompson WG, Dotewall G, Drossman DA, et al. Irritable bowel syndrome: guidelines for the diagnosis. Gastroenterol Int 1989; 2: 925.
  • 4
    Thompson WG, Longstreth GF, Drossman DA, et al. Functional bowel disorders and functional abdominal pain. Gut 1999; 45 (Suppl. II): II437.
  • 5
    Hunt RH. Evolving concepts in the pathophysiology of functional gastrointestinal disorders. J Clin Gastroenterol 2002; 35: S26.
  • 6
    Balsari A, Ceccarelli A, Dubini F, Fesce E, Poli G. The fecal microbial population in the irritable bowel syndrome. Microbiologica 1982; 5: 18594.
  • 7
    Treem WR, Ahsan N, Kastoff G, Hyams JS. Fecal short-chain fatty acids in patients with diarrhea-predominant irritable bowel syndrome: in vitro studies of carbohydrate fermentation. J Pediatr Gastroenterol Nutr 1996; 23: 2806.
  • 8
    King TS, Elia M, Hunter JO. Abnormal colonic fermentation in irritable bowel syndrome. Lancet 1998; 352: 11879.
  • 9
    Giacometti A, Cirioni O, Fiorentini A, Fortuna M, Scalise G. Irritable bowel syndrome in patients with Blastocystis hominis infection. Eur J Clin Microbiol Infect Dis 1999; 18: 4369.
  • 10
    Pimentel M, Chow EJ, Lin HC. Normalization of lactulose breath testing correlates with symptom improvement in irritable bowel syndrome. A double-blind, randomized, placebo-controlled study. Am J Gastroenterol 2003; 98: 4129.
  • 11
    Malinen E, Rinttila T, Kajander K, et al. Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR. Am J Gastroenterol 2005; 100: 37382.
    Direct Link:
  • 12
    Corazza GR, Menozzi MG, Strocchi A, et al. The diagnosis of small bowel bacterial overgrowth. Reliability of jejunal culture and inadequacy of breath hydrogen testing. Gastroenterology 1990; 98: 3029.
  • 13
    Singh VV, Toskes PP. Small bowel bacterial overgrowth: presentation, diagnosis, and treatment. Curr Treat Options Gastroenterol 2004; 7: 1928.
  • 14
    Kerlin P, Wong L. Breath hydrogen testing in bacterial overgrowth of the small intestine. Gastroenterology 1988; 95: 9828.
  • 15
    Pimentel M, Chow EJ, Lin HC. Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome. Am J Gastroenterol 2000; 95: 35036.
    Direct Link:
  • 16
    Pimentel M, Kong Y, Park S. Breath test to evaluate lactose intolerance in irritable bowel syndrome correlates with lactulose testing and may not reflect true lactose malabsorption. Am J Gastroenterol 2003; 98: 27004.
    Direct Link:
  • 17
    Walters B, Vanner SJ. Detection of bacterial overgrowth in IBS using the lactulose H2 breath test: comparison with 14C-D-xylose and healthy controls. Am J Gastroenterol 2005; 100: 156670.
    Direct Link:
  • 18
    Riordan SM, McIver CJ, Walzer BM, Duncombe VM, Bolin TD, Thomas MC. The lactulose breath hydrogen test and small intestinal bacterial overgrowth. Am J Gastroenterol 1996; 91: 1795803.
  • 19
    Van Citters GW, Lin HC. Management of small intestinal bacterial overgrowth. Curr Gastroenterol Rep 2005; 7: 31720.
  • 20
    Olden KW. Diagnosis of irritable bowel syndrome. Gastroenterology 2002; 122: 170114.
  • 21
    Harder H, Serra J, Azpiroz F, Passos MC, Aguadé S, Malagelada J-R. Intestinal gas distribution determines abdominal symptoms. Gut 2003; 52: 170813.
  • 22
    Nucera G, Lupascu A, Gabrielli M, et al. Abnormal breath test to lactose, fructose and sorbitol in irritable bowel syndrome may be explained by small intestinal bacterial overgrowth. Aliment Pharmacol Ther 2005; 21: 13915.
  • 23
    Yang CY, Chang CS, Chen GH. Small-intestinal bacterial overgrowth in patients with liver cirrhosis, diagnosed with glucose H2 or CH4 breath tests. Scand J Gastroenterol 1998; 33: 86771.